Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or
Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726)
06/2014
06/26/2014US20140178354 Salinosporamides and Methods of Use Thereof
06/26/2014US20140178336 Antiviral compounds
06/25/2014EP2746286A1 Aminated derivative of homoharringtonine, preparation method therefor, and application thereof
06/25/2014EP2746285A1 Process for the preparation of aurora kinase inhibitors
06/25/2014CN103889989A 稠合杂环衍生物及其制药用途 Fused heterocyclic derivatives and pharmaceutical use
06/25/2014CN103889951A 唑类衍生物 Azole derivative
06/25/2014CN103880854A 木果楝碱甲素、其制备方法和其用途 A plain wooden fruit neem base, their preparation and their use
06/25/2014CN103880853A 罗丹明6g酰肼衍生物、其制备方法、应用及作为荧光探针对次氯酸进行荧光分析的方法 Rhodamine 6g hydrazide derivatives, their preparation, and methods of application as fluorescent probes for fluorescence analysis of hypochlorous
06/25/2014CN103880823A 作为丙型肝炎抑制剂的螺环化合物及其在药物中的应用 As spiro compound inhibitors of hepatitis C and its application in medicine
06/25/2014CN102516258B 水溶性维生素e衍生物修饰的脂溶性抗癌药物化合物和制剂、该化合物的制备方法及应用 Derivative modified with water-soluble vitamins e liposoluble anticancer drug compounds and formulations of the compounds and the preparation of applications
06/25/2014CN102459279B 治疗剂713 Therapeutic agent 713
06/25/2014CN102382119B 一种汉防已甲素和汉防已乙素的提取方法 An extraction method Tetrandrine hormone and Chinese defense has been HB's
06/25/2014CN102224156B 蛋白酶抑制剂 Protease inhibitors
06/25/2014CN101759645B p38抑制剂及它们的使用方法 p38 inhibitors and methods for their use
06/24/2014US8759357 Inhibitors of fatty acid binding protein (FABP)
06/24/2014US8759341 Bi- and tricyclic indazole-substituted 1,4-dihydropyridine derivatives and uses thereof
06/19/2014WO2014093677A1 Recognition of cellular target binding by a bioactive agent using intracellular bioluminescence resonance energy transfer
06/19/2014WO2014092544A1 A sensor for determining calcium ions
06/19/2014WO2014092100A1 Heterocyclic compound
06/19/2014US20140171645 Electrophilic alkylating reagents, their preparation and use
06/19/2014US20140171643 Methods for making 3-o-protected morphinones and 3-o-protected morphinone dienol carboxylates
06/19/2014US20140171461 Nitrogen Containing Morphinan Derivatives and the Use Thereof
06/19/2014US20140171427 Heterocyclic chromene-spirocyclic piperidine amides as modulators of ion channels
06/19/2014US20140171416 Cephalotaxus esters, methods of synthesis, and uses thereof
06/19/2014US20140171336 Methods and Kits Using Extended Rhodamine Dyes
06/18/2014EP2742033A1 Flavonoid compounds, and methods of use thereof
06/18/2014EP2742030A1 1,2,4-triazolyl-substituted keto-enols
06/18/2014CN103864812A Achiral amphipathic zinc phthalocyanine and spiral nanowire prepared by taking achiral amphipathic zinc phthalocyanine as raw material
06/18/2014CN103864811A Novel 10-hydroxy camptothecin site-20 derivative preparation method, and application of 10-hydroxy camptothecin site 20 derivative in anti-tumor drugs
06/18/2014CN103864810A Preparation method of novel 10-hydroxycamptothecine 10-position derivatives and application in antitumor drugs
06/18/2014CN103864809A Salt of oxocrebanine derivative
06/18/2014CN103864808A Salts of (-)sukhodianine derivative
06/18/2014CN103864807A Salts of dioxo-dehydrocrebanine derivative
06/18/2014CN103864806A Salts of crebanine derivative
06/18/2014CN103864805A Salts of dehydrocrebanine derivative
06/18/2014CN103864804A Synthetic method for pranoprofen
06/18/2014CN103864803A Preparation of 1-(phenyl)-1, 3, 4, 9-tetrahydropyrano[3, 4-b]indole derivative and application in antitumor drugs
06/18/2014CN103864802A Preparation method of high-purity asenapine maleate
06/18/2014CN103864801A Pyrazole spiro derivatives as well as preparation method and bactericide application thereof
06/18/2014CN103864783A Compounds for the Treatment of Hepatitis C
06/18/2014CN103864770A Pyrimidinamine and pyridinamine Hedgehog signal conduction inhibitors
06/18/2014CN102627632B Amino quinazoline derivative and preparation method as well as application thereof
06/18/2014CN102209711B Compounds for the treatment of hepatitis C
06/18/2014CN102171215B 7H-imidazo[1, 2-a]pyrano[2, 3-c]pyridine derivations and the use thereof
06/18/2014CN102007124B Pyrimidine-2-amine compounds and their use as inhibitors of jak kinases
06/17/2014US8754190 Controlled release from macromolecular conjugates
06/17/2014US8754103 Fused heterocyclic compounds as ion channel modulators
06/17/2014US8754101 N-cyclobutyl-imidazopyridine-methylamine as TRPV1 antagonists
06/17/2014US8754100 Nitrogen-containing fused heterocyclic compounds and their use as beta amyloid production inhibitors
06/17/2014US8754082 Antiviral drugs for treatment of Arenavirus infection
06/17/2014CA2656566C Dihydrofuro pyrimidines as akt protein kinase inhibitors
06/12/2014WO2014088300A1 Organic electroluminescence compounds and organic electroluminescence device comprising the same
06/12/2014WO2014088085A1 Pyridone compound
06/12/2014WO2014086806A1 Pyridine-2-amides useful as cb2 agonists
06/12/2014WO2014086805A1 Pyridine-2-amides useful as cb2 agonists
06/12/2014WO2014086291A1 Method for preparing ticagrelor and intermediates thereof
06/12/2014WO2014086102A1 Indole full ketone derivative used as tyrosine-kinase inhibitor
06/12/2014WO2014086099A1 Glucopyranosyl derivative, preparation method and medical use thereof
06/12/2014US20140163231 Hepatitis C Virus Inhibitors
06/12/2014US20140163219 HCV Protease Inhibitors
06/12/2014US20140163083 Novel crystalline salts of asenapine
06/12/2014US20140163035 Heterocyclic amide derivatives as p2x7 receptor antagonists
06/12/2014US20140163012 Pyrido-/azepino-benzofuran and pyrido-/azepino-benzothiophene mch-1 antagonists, methods of making, and use thereof
06/12/2014US20140163001 Heterocyclic compound
06/12/2014US20140163000 Compounds useful as inhibitors of atr kinase
06/12/2014US20140162985 Heterocyclic nuclear hormone receptor modulators
06/12/2014US20140161801 Quinazoline derivative as tyrosine-kinase inhibitor, preparation method therefor and application thereof
06/12/2014US20140161731 3,6-disubstituted xanthylium salts
06/12/2014US20140161729 Cofluorons and methods of making and using them
06/11/2014EP2740734A1 Hcv protease inhibitors
06/11/2014EP2739629A1 Compounds for treating respiratory syncytial virus infections
06/11/2014CN103857682A Azetidine derivatives for treatment of melanin related disorders
06/11/2014CN103857680A Novel organic electroluminescent compounds and organic electroluminescent device using the same
06/11/2014CN103857661A 1,2,4-triazolyl-substituted keto-enols
06/11/2014CN103849377A Rhodamine B-based fluorescent sensor, preparation and application thereof
06/11/2014CN103848840A Camptothecin derivatives and medical application thereof
06/11/2014CN103848839A Synthesis method of pyran[2,3-b]pyridine derivatives
06/11/2014CN103848821A Spiro compound serving as hepatitis C inhibitor, drug composition and applications of spiro compound and drug composition
06/11/2014CN103848820A Spiro compound serving as hepatitis C inhibitor and applications thereof in drugs
06/11/2014CN103848819A Spiro compound serving as hepatitis C inhibitor, drug composition and applications of spiro compound and drug composition in drugs
06/11/2014CN103848818A Parallel ring compound serving as hepatitis C inhibitor, drug composition and applications of parallel ring compound and drug composition in drugs
06/11/2014CN103848806A Glucopyranosyl derivative as well as preparation method and application thereof in medicines
06/11/2014CN103172641B Heterocyclic amino and alkoxy-replaced quinazoline derivative and application thereof
06/11/2014CN102140100B Polycyclic compound for inhibiting hepatitis C virus efficiently, preparation method thereof and application thereof
06/10/2014US8748455 Solid forms of a pharmaceutically active substance
06/05/2014WO2014084330A1 Nitrogen-containing heterocyclic compound
06/05/2014WO2014084323A1 Transparent electrode, and electronic device
06/05/2014WO2014083529A1 Heterocyclic compounds as inhibitors of the sodium iodide symporter
06/05/2014WO2014083038A1 Pesticidally active tricyclic pyridyl derivatives
06/05/2014WO2014082381A1 Spiro ring compounds as hepatitis c virus inhibitors, pharmaceutical compositions and uses thereof
06/05/2014WO2014082379A1 Spiro ring compound as hepatitis c virus (hcv) inhibitor and uses thereof field of the invention
06/05/2014US20140155423 Berbamine derivatives
06/05/2014US20140155387 Anti-Inflammation Compounds
06/04/2014EP2738173A1 Heterocyclic compounds as inhibitors of the sodium iodide symporter
06/04/2014EP2738171A1 Pesticidally active tricyclic pyridyl derivatives
06/04/2014EP2738166A1 Nitrogenated aromatic heterocyclic derivative, and organic electroluminescent element using same
06/04/2014EP2736906A1 N-(IMIDAZOLIDIN-2-YLIDENE)-HETEROCYCLOPENTA[b]PYRIDINE DERIVATIVES AS MODULATORS OF ALPHA 2 ADRENERGIC RECEPTORS
06/04/2014EP2736901A1 Heterocyclyl pyrimidine analogues as jak inhibitors
06/04/2014EP2736886A1 Substituted quinolines and their use as medicaments
06/04/2014CN1585772B Chemokine receptor antagonists and methods of use thereof
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 ... 298